A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from ...
A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from ...
ENHERTU Showed Statistically Significant Improvement in IDFS vs. T-DM1 in High-Risk Early Breast Cancer After Neoadjuvant ...
Positive high-level results from a planned interim analysis of the DESTINY-Breast05 Phase III trial showed ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated a highly statistically significant an ...
A 55-year-old woman develops triple-negative breast cancer, rectal adenocarcinoma, and HBV reactivation during pembrolizumab ...
New research shows lymph nodes aren’t just cancer bystanders, they’re the command centers fueling immune attacks. Surgically ...
The DESTINY-Breast05 trial included patients with HER2-positive primary breast cancer who were at high risk of recurrence and had residual invasive disease in breast or axillary lymph nodes following ...
For patients with high-risk HER2-positive early breast cancer who have undergone neoadjuvant therapy, treatment with Enhertu ...
Positive high-level results from a planned interim analysis of the DESTINY-Breast05 Phase III trial showed ENHERTU demonstrated a highly ...
Positive topline results from a planned interim analysis of the DESTINY-Breast05 phase 3 trial showed ENHERTU demonstrated a highly statistically ...
For patients undergoing a blood draw, various factors including illness, dehydration and anxiety may hinder phlebotomists ...
News Medical on MSN
Leading cancer societies update clinical guideline on post-mastectomy radiation therapy
Three leading national cancer organizations today issued an updated guideline on post-mastectomy radiation therapy (PMRT) for physicians treating patients with breast cancer. The American Society for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback